Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms.
Mackenzie R, Kommoss S, Winterhoff BJ, Kipp BR, Garcia JJ, Voss J, Halling K, Karnezis A, Senz J, Yang W, Prigge ES, Reuschenbach M, Doeberitz MV, Gilks BC, Huntsman DG, Bakkum-Gamez J, McAlpine JN, Anglesio MS.
Mackenzie R, et al. Among authors: kipp br.
BMC Cancer. 2015 May 19;15:415. doi: 10.1186/s12885-015-1421-8.
BMC Cancer. 2015.
PMID: 25986173
Free PMC article.